Announcement of The Financial Report for The Year of 2021
2022.3.9
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 3 | Date of announcement | 2022/03/09 | Time of announcement | 21:09:12 |
| Subject | Announcement of The Financial Report for The Year of 2021 | ||||
| Date of events | 2022/03/09 | To which item it meets | paragraph 31 | ||
| Statement | 1.Date of the board of directors submitted or approved:2022/03/09 2.Date of the audit committee approved:2022/03/09 3.Start and end dates of financial reports or unaudited finanacial information of the reporting period:2021/01/01~2021/12/31 4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):4,535,610 5.Gross profit (loss) from operations accumulated from 1/1 to end of the period (thousand NTD):2,766,553 6.Net operating income (loss) accumulated from 1/1 to end of the period (thousand NTD):1,140,652 7.Profit (loss) before tax accumulated from 1/1 to end of the period (thousand NTD):1,087,380 8.Profit (loss) accumulated from 1/1 to end of the period (thousand NTD):822,569 9.Profit (loss) during the period attributable to owners of parent accumulated from 1/1 to end of the period (thousand NTD):831,894 10.Basic earnings (loss) per share accumulated from 1/1 to end of the period (NTD):3.35 11.Total assets end of the period (thousand NTD):9,296,465 12.Total liabilities end of the period (thousand NTD):3,529,231 13.Equity attributable to owners of parent end of the period (thousand NTD):5,167,855 14.Any other matters that need to be specified:None. |
||||